I do follow Boon's analysis at Valuebuddies. His views are incisive and well considered.
I agree that the latest business venture is synergistic and dove tail nicely into BW's personal healthcare business model.
The plate is quite full for BW for the next 6 months and the key to its further success will lie with its execution of its plans and strategies.
To enhance liquidity of its shares and to attract institutional shareholders, I agree that a bonus issue should be declared in its impending 1H results.
Given that China is the 2nd largest MLM market globally and its rising growth of the consumer market, coupled with the sunrise sector of the personal beauty care/healthcare industry, BW is well positioned to ride on these secular trends in China. I am particularly excited about the dental stem cell business and this segment can scale up quite fast given its growing distribution channels.
BW must remain focused and disciplined to execute its strategies and plans well. Share price will take care of itself once the business growth strengthens. I am confident over Dora's business acumen and the future of BW..